Stem cells & age-related frailty

Arrow Left Go back to previous page Back to News

Stem cells & age-related frailty


“Remarkable improvements” have been seen after using Stem Cell Research to combat age-related frailty.

Frailty is a geriatric syndrome which unfortunately decreases mobility of elderly people as well as the health of older people. It is said that frailty effects around 7% of the British population above 65.

The symptoms of frailty range from weakness, a lower grip strength, muscle loss as well as weight loss, decreased energy, and increased likelihood of catastrophic injury.

The University of Miami Miller School of Medicine, in America, have been doing incredible research into how Mesenchymal stem cells could fight frailty both safely and effectively. This has been suggested by researchers at the Interdisciplinary Stem Cell Institute (ISCI) within the university.

After doing multiple trails on 30 participants, they found that improvements were being reported for physical performance.

These improvements were shown with a the 6-minute walking test and short physical performance exam.

David G. Le Couter, a professor of medicine at the University of Sydney, praised this new breakthrough, commenting;

“These trials represent potential landmarks in the treatment of frailty.”

The findings have been academically acclaimed by multiple experts such as Joshua M. Hare, the Louis Lemberg Professor of Medicine, stating that this new stem cell therapy development for frailty is “ground breaking”.

Throughout our lives we can keep fit and healthy and try to exercise as much as our busy lives allow but, getting older is a part of life and there are no quick fixes make the later years in life easier.

Although through this stem cell development trail, there is now promising research to suggest that Mesenchymal stem cells could well be the answer to a healthier and a more mobile retirement.

Mesenchymal stem cells, are the same as the cells found in dental pulp, and were used in this trail.

We believe the best stem cells to use in emerging treatments will be the patient’s own stem cells as this doesn’t require a search for a suitable donor and in turn, eliminates chances of the transplanted cells being rejected.